Emerald Health Therapeutics Inc

Emerald Health Therapeutics positioning itself for 'Cannabis 2.0'

Emerald Health Therapeutics Inc (TSXV:EMH) (OTCQX:EMHTF) Vice President Bernie Hertel tells Proactive Investors the Vancouver-based cannabis company is positioning itself for 'Cannabis 2.0', the 17 October 2019 date where regulations change in Canada, and edibles, infused beverages, topicals, concentrates, and vapes will be officially available for sale in mid-December.

Hertel says while the company hasn't disclosed what their product line will look like, the company is 'working behind the scenes' to deliver new products. The company recently received its processing license from Health Canada for its greenhouse facility at its 50%-owned joint venture, Pure Sunfarms.

Quick facts: Emerald Health Therapeutics Inc

Price: $2.04

Market: TSX-V
Market Cap: $292.89 m


e-Therapeutics’ Barlow hails deals with Novo Nordisk and ‘top five pharma...

Ray Barlow, chief executive of e-Therapeutics (LON:ETX), talks to Proactive’s Andrew Scott about the company’s unique approach to drug discovery, which uses computational techniques to find potential breakthrough new treatments. He also provided some insight into recent tie-ups with Denmark’s...

4 days, 16 hours ago

2 min read